期刊文献+

西妥昔单抗联合照射对结直肠癌CL187细胞的抑制作用及机制探讨 被引量:5

Inhibitory effect of combination of cetuximab and irradiation on colorectal carcinoma CL187 cells
原文传递
导出
摘要 目的研究西妥昔单抗(C225)联合外照射对结直肠癌CL187细胞生物学效应的影响,并探讨相关分子机制。方法结直肠癌CL187细胞分单纯照射组和C225处理的联合照射组,受6MVX射线照射0、4和8Gy后24和48h,用四甲基偶氮唑盐(MTT)比色法测吸光度(A)值,比较两组细胞死亡率的差异。利用克隆形成实验比较两组细胞增殖能力的差异。采用流式细胞仪,检测细胞周期和细胞凋亡。蛋白免疫印迹法分析两组细胞DNA—PKcs、Ku70和Ku80蛋白表达量的变化。结果联合照射组较单纯照射组死亡细胞比例增加(t=-6.14、-6.53,P〈0.05),细胞克隆形成能力下降。C225增强了射线对细胞的杀伤作用,放射增敏比SER为1.38。联合照射组G0/G1期细胞阻滞增加(t=-4.64,P〈0.05),细胞凋亡比例增加(t=-9.16,P〈0.05),DNA修复相关蛋白DNA—PKcs、Ku70和Ku80蛋白表达量减少。结论西妥昔单抗增强照射对结直肠癌CL187细胞的杀伤作用,可能是通过影响细胞周期、细胞凋亡和DNA损伤修复基因实现的。 Objective To investigate the combination effect of cetuximab and irradiation on colorectal carcinoma CL187 cell line and underlying molecular mechanism. Methods CL187 cells with or without cetuximab treatment were irradiated by 0, 4 and 8 Gy X-rays, then cell death percentage was determined by MTT 24 and 48 h post-irradiation. Clone forming assay was used to evaluate the cell reproliferation ability. Cell cycle distribution, apoptosis, and necrosis were analyzed by flow eytometry. Western blot was used to detect the protein expressions of DNA-PKcs, Ku70 and KuS0. Results The cetuximab enhanced the percentage of radiation-induced cell death, while descreased the cloning formation capacity and increased radiosenvtivity (t = - 6. 14, - 6.53, P 〈 0.05). The SER of cetuximab on CL187 cell line approached to 1.38. In addition, cetuximab also increased radiation-induced G0/G1 phase arrest (t= -4.64, P〈0.05) and the percentage ofapoptosis and necrosis (t = -9.16, P〈0.05), but it descreased the expression levels of DNA-PKcs, KuT0 and KuS0 proteins. Conclusions The cetuximab treatment might enhance the inhibitory effect of irradiation on colorectal carcinoma CL187 cell line by influencing cell cycle distribution, cell apoptosis, and the expression of DNA repair proteins.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2012年第5期481-484,共4页 Chinese Journal of Radiological Medicine and Protection
基金 基金项目:国家自然科学基金(81071834)
关键词 西妥昔单抗 结直肠癌 CL187细胞 DNA损伤 Cetuximab Colorectal carcinoma CL187 cell line DNA damage
  • 相关文献

参考文献15

  • 1Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med, 2009, 360 (14) : 1408-1417.
  • 2Bakemeyer C, Bondarenko I, Makhson A, et a1. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clio Oneol, 2009, 27 (5) :663-671.
  • 3Bonner JA, Harari PM, Giralt J, et a1. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5- year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. The Lancet Oncology, 2010, 11 ( 1 ) :21-28.
  • 4Nielsen MB, Laurberg S, Holm T, et al. Current management of locally recurrent rectal cancer. Colorectal Dis, 2011, 13 (7 ) : 732 .. 742.
  • 5Wiig IN, Larsen SG, Dueland S, et al. Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome. Colorectal Dis, 2011,13(5) :506-511.
  • 6Lee JH, Kim DY, Kim SY, et al. Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer. Radiat Oncol , 2011 , 6 ( 1 ) : 51- 58 .
  • 7Sun DS, Zhang JD, Li L, et al. Accelerated hyperfractionation field-involved re-irradiation combined with concurrent cape citabine chemotherapy for locally recurrent and irresectable rectal cancer. Br J Radiol, 2011 , 84 (996) :221-228.
  • 8Horisberger K, Treschl A, Mai S , et al. Cetuximab in combination with capecitahine , irinotecan , and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. Int J Radiat Oncol BioI Phys, 2009, 74 (5 ) : 1487-1493.
  • 9Bertolini F, Chiara S, Bengala C, et al. Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer. Int J Radiat Oncol Bioi Phys, 2009, 73 ( 2) : 466 - 472.
  • 10Huang SM, Bock JM and Harari PM. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res, 1999,59(8): 1935-1940.

同被引文献85

  • 1张均田.现代药理实验方法[M].北京:北京医科大学中国协和医科大学联合出版社,1996.1225.
  • 2张均田.现代药理实验方法[M].北京:北京医科大学中国协和医科大学联合出版社,1998.1151.
  • 3Burgess AW. EGFR family:structure physiology signaling and therapeutic targets [ J ]. Growth Factors, 2008,26 ( 5 ) : 263 - 274.
  • 4Miqueli AD, Rolff J, Lemm M, et al. Radiosensitisation of U87MG brain tumours by anti -epidermal growth factor re- ceptor monoclonal antibodies [ J]. Br J Cancer,2009,100 (6) :950 -958.
  • 5Rades D, Wolff C, Nadrowitz R, et al. Radioactive EGFR an- tibody Cetuximab in muhimodal cancer treatment:stability and synergistic effects with radiotherapy [ J ]. Int J Radiat Oneol Biol Phys, 2009,75 (4) : 1226 - 1231.
  • 6Rosell R, Moran T, Carcereny E, et al. Non - small - cell lung cancer harbouring mutations in the EGFR kinase do- main [ J ]. Clin Transl Oncol,2010,12 : 75 - 80.
  • 7Krause M, Prager J, Zhou X, et al. EGFR - TK inhibition before radiotherapy reduces turnout volume but does not improve local control:Differential response of cancer stem ceils and nontumourigenic cells [ J ]. Radiother Oncol, 2007,83 ( 3 ) : 316 - 325.
  • 8Hagan M, Yacoub A, Dent P. Ionizing radiation causes a dose - dependent release of transforming growth factor al- pha in vitro from irradiated xenografts and during palliative treatment of hormone - refractory prostate carcinoma [ J ]. Clin Cancer Res ,2004,10:5724 - 5731.
  • 9Peltola K, Hollmen M, Maula SM, et al. Pim - 1 kinase ex- pression predicts radiation response in squamocellular car- cinoma of head and neck and is under the control of epi- dermal growth factor receptor [ J ]. Neoplasia, 2009, 11 (7) :629 -636.
  • 10Liccardi G, Hartley JA, Hochhauser D. EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment[ J]. Cancer Res ,2011,71 (3) :1103 - 1114.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部